Epoxidation of Allyl-Substituted Alkenes
TABLE 3. Epoxidation of Allyic Terminal Alkenes 5 by
As illustrated in Table 3, the “1 + Oxone” oxidation
system could achieve erythro-selective epoxidation of
phthalimide-protected allylic amines 5c-e and Boc-
a
Mn-porphyrins
protected allylic amine 5f in high yields. For epoxidation
of 5c bearing a benzyl group, epoxide 6c1
8a,c
could be
achieved with erythro selectivity of 3.4:1 in 96% isolated
yield based on 88% conversion, while m-CPBA provided
major product threo-epoxide 6c with a selectivity of 1:3.
It should be noted that this is the first example in which
major product erythro 6c was obtained via direct epoxi-
dation of 5c. By conducting the epoxidation at 0 °C,
erythro selectivity of 3.6:1 could be attained (Table 3,
entry 6). With [Mn(F20-TPP)Cl] as the catalyst, erythro
selectivity of 1.3:1 was obtained (entry 7). For epoxidation
of 5d with an isopropyl group, an increase in erythro
selectivity to 5:1 was observed (entry 8), indicating that
this epoxidation is sensitive to the steric bulkiness of the
R-substituent. For 5e and Boc-protected 5f, erythro
selectivities of 1.8:1 and 1.4:1 were observed, respectively
(
entries 9 and 10). It should be noted that m-CPBA gave
threo-epoxides as major products in the epoxidation of
d (1:3), 5e (1:4), and 5f (1:13). For epoxidation of allylic
esters 5g and 5h using 1 as a catalyst, 1:1 mixtures of
5
2
1
epoxides were observed (entries 11 and 12) in 1 h.
Stereoselective Epoxidation of Glycals. Glycal
epoxides have been shown to be important intermediates
for oligosaccharide synthesis and could be prepared by
2
2
dimethyl dioxirane-mediated glycal epoxidation. How-
ever, the isolation and large-scale preparation of dimethyl
dioxirane would be tedious. In addition, poor facial
a
Unless otherwise indicated, all the epoxidation reactions were
selectivity resulted in epoxidation of glycals bearing small
performed as follows: To a CH3CN/H2O solution of alkene (0.1
mmol), NH4OAc (0.05 mmol) and catalyst (0.5 µmol) was added
Oxone (0.13 mmol) and NH4HCO3 (0.4 mmol) at room temperature
22a,23
substituents such as tri-O-acetylglycal 7.
In this
regard, we were interested to examine the activity of 1
in epoxidation of 7.24 To minimize the possibility of
b
1
c
(
Reaction time: 1 h). Determined by H NMR. Epoxidations
were carried out in CH2Cl2 with an alkene/m-CPBA/NaHCO3
2 2
epoxide hydrolysis by water, urea-H O was used as the
molar ratio of 1:2:3. d To a solution of alkene (0.2 mmol), NH4OAc
(
0.03 mmol), and 1 (2 µmol) in CH3CN (4 mL) was added a
(17) (a) Rotella, D. P. Tetrahedron Lett. 1995, 36, 5453. (b) Albeck,
A.; Estreicher, G. I. Tetrahedron 1997, 53, 5325. (c) Kim, B. M.; Bae,
S. J.; So, S. M.; Yoo, H. T.; Chang, S. K.; Lee, J. H.; Kang, J. Org. Lett.
2001, 3, 2349. (d) Wang, D.; Schwinden, M. D.; Radesca, L.; Patel, B.;
Kronenthal, D.; Huang, M.-H.; Nugent, W. A. J. Org. Chem. 2004, 69,
premixed solution of NH4HCO3 (0.6 mmol), CH3CN (0.5 mL), H2O
(
0.5 mL), and 35% H2O2 (0.1 mL) at room temperature (Reaction
time: 2 h). Isolated yield based on 88% conversion. f At 0 °C for
e
g
5
h. Mn(F20-TPP)Cl was used instead of 1.
1
629.
18) For other methods, see: (a) Parkes, K. E. B.; Bushnell, D. J.;
(
Crackett, P. H.; Dunsdon, S. J.; Freeman, A. C.; Gunn, M. P.; Hopkins,
R. A.; Lambert, R. W.; Martin, J. A.; Merrett, J. H.; Redshaw, S.;
Spurden, W. C.; Thomas, G. J. J. Org. Chem. 1994, 59, 3656. (b)
Branalt, J.; Kvarnstrom, I.; Classon, B.; Samuelsson, B.; Nillroth, U.;
Danielson, U. H.; Karlen, A.; Hallberg, A. Tetrahedron Lett. 1997, 38,
3
483. (c) Aguilar, N.; Moyano, A.; Pericas, M. A.; Riera, A. J. Org.
Chem. 1998, 63, 3560. (d) Kurihara, M.; Ishii, K.; Kasahara, Y.; Miyata,
N. Tetrahedron Lett. 1999, 40, 3183.
(
19) Using m-CPBA as the oxidant, mixtures of erythro- and threo-
epoxides were obtained, see: (a) Luly, J. R.; Dellaria, J. F.; Plattner,
J. J.; Soderquist, J. L.; Yi, N. J. Org. Chem. 1987, 52, 1487. (b) Roush,
W. R.; Straub, J. A.; Brown, R. J. J. Org. Chem. 1987, 52, 5127. (c) Li,
Y.-L.; Luthman, K.; Hacksell, U. Tetrahedron Lett. 1992, 33, 4487. (d)
Romeo, S.; Rich, D. H. Tetrahedron Lett. 1993, 34, 7187. (e) Albeck,
A.; Persky, R. J. Org. Chem. 1994, 59, 653. (f) Jenmalm, A.; Berts, W.;
Li, Y.-L.; Luthman, K.; Csoeregh, I.; Hacksell, U. J. Org. Chem. 1994,
5
9, 1139. (g) Romeo, S.; Rich, D. H. Tetrahedron Lett. 1994, 35, 4939.
20) For the use of a polymer-supported ruthenium porphyrin
catalyst to synthesize threo-6f, see ref 7c.
FIGURE 4. Synthetic utilities of erythro-allyic amino ep-
(
oxides.
(
21) For a selected example on the synthetic utility of erythro-6g,
see: Chung, S. J.; Chung, S.; Lee, H. S.; Kim, E.-J.; Oh, K. S.; Choi,
key synthetic intermediates for the construction of
Saquinavir and Amprenavir (Figure 4). Currently, these
H. S.; Kim, K. S.; Kim, Y. J.; Hahn, J. H.; Kim, D. H. J. Org. Chem.
2
001, 66, 6462. Note that with m-CPBA as the oxidant, epoxidations
erythro-epoxides have been obtained by ring-closure
of 5g and 5h required a few days for complete conversion.
reactions of â-halohydrins.1
7,18
(22) (a) Halcomb, R. L.; Danishefsky, S. J. J. Am. Chem. Soc. 1989,
11, 6661. (b) Danishefsky, S. J.; Bilodeau, M. T. Angew. Chem. Int.
However, m-CPBA epoxi-
1
dation could only afford threo-epoxides as major prod-
Ed. Engl. 1996, 35, 1380.
19,20
(23) Kim, H. M.; Kim, I. J.; Danishefsky, S. J. J. Am. Chem. Soc.
ucts.
Up to now, there is no direct epoxidation method
2
001, 123, 35.
available to access these erythro-amino epoxide major
products.
(
24) For the use of a ruthenium porphyrin catalyst in R-selective
epoxidation of glycal, see ref 7a.
J. Org. Chem, Vol. 70, No. 11, 2005 4229